Combined treatment with electrical stimulation and insulin-like growth factor-1 promotes bone regeneration in vitro

PLoS One. 2018 May 10;13(5):e0197006. doi: 10.1371/journal.pone.0197006. eCollection 2018.

Abstract

Electrical stimulation (ES) and insulin-like growth factor-1 (IGF-1) are widely used in bone regeneration because of their osteogenic activity. However, the combined effects of ES and supplemental IGF-1 on the whole bone formation process remain unclear. In this study, fluorescence staining and an MTT assay were first utilized to observe the influence of ES and IGF-1 on MC3T3-E1 cell proliferation and adhesion in vitro. Subsequently, osteogenic differentiation was evaluated by the alkaline phosphatase activity (ALP) and the expression of osteogenic marker genes. In addition, cell mineralization was determined by alizarin red staining and scanning electron microscopy (SEM). We demonstrated that the MC3T3-E1 cell proliferation was significantly higher for treatments combining IGF-1 and ES than for treatments with IGF-1 alone. The combination of IGF-1 and ES increased the MC3T3-E1 cell ALP activity, the expression of osteogenesis-related genes and the calcium deposition with a clear dose-dependent effect. Our data show the synergistic effect of IGF-1 and ES in promoting the proliferation, differentiation and mineralization of MC3T3-E1 cells, which suggests that it would be more effective to combine the proper dose of IGF-1 with ES to promote local bone damage repair and regeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Regeneration / drug effects*
  • Cell Differentiation / drug effects*
  • Cell Line
  • Electric Stimulation Therapy*
  • Insulin-Like Growth Factor I / pharmacology*
  • Mice
  • Osteoblasts / metabolism*
  • Osteoblasts / pathology
  • Osteogenesis / drug effects*

Substances

  • insulin-like growth factor-1, mouse
  • Insulin-Like Growth Factor I

Grants and funding

This study was supported by the National Natural Science Foundation of China (No. 81672263 to XY, and No. 31572217).